22Nd Century Group (XXII) closed at $0.20 on October 23, 2026, down 8.5% from the previous close, on volume of 59,567,096 shares (30-day average 5,404,192).
Data as of October 23, 2026.
22nd Century Group Expands At-The-Market Stock Offering
TipRanks (Fri, 23-Oct 5:49 PM ET)
Oil Above $100 Puts Penny Stocks in Focus
Globe Newswire (Fri, 23-Oct 11:59 AM ET)
XXII jumps as preliminary Q3 results show 66% revenue growth and a return to gross profit
Market Chameleon (Fri, 23-Oct 5:52 AM ET)
Market Chameleon (Thu, 22-Oct 6:58 AM ET)
22nd Century Reports Strong Q3 Revenue and Profitability Gains
TipRanks (Thu, 22-Oct 10:57 AM ET)
22nd Century Group Preliminarily Reports Third Quarter Financial Results
Globe Newswire (Thu, 22-Oct 10:35 AM ET)
22nd Century Same Store Unit Sales for Pinnacle VLN and Pinnacle Pure Surge 161%
Globe Newswire (Thu, 15-Oct 4:30 PM ET)
Globe Newswire (Mon, 28-Sep 9:15 AM ET)
Globe Newswire (Thu, 24-Sep 5:42 PM ET)
Globe Newswire (Tue, 1-Sep 8:00 AM ET)
22nd Century Group Inc is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The company manufactures and distributes the only combustible tobacco products containing minimally or non-addictive levels of nicotine. The Company has organized its business as a single reportable segment: tobacco, as it operates and derives all revenues from its tobacco operations and products.
22Nd Century Group trades on the NASDAQ stock market under the symbol XXII.
As of October 23, 2026, XXII stock price declined to $0.20 with 59,567,096 million shares trading.
XXII has a beta of 3.12, meaning it tends to be more sensitive to market movements. XXII has a correlation of 0.02 to the broad based SPY ETF.
XXII has a market cap of $141,157.00. This is considered a Sub-Micro Cap stock.
Last quarter 22Nd Century Group reported $3 million in Revenue and -$15.60 earnings per share. This fell short of revenue expectation by $-5 million and missed earnings estimates by -$15.30.
In the last 3 years, XXII traded as high as $536,079.90 and as low as $.18.
XXII has underperformed the market in the last year with a price return of -99.4% while the SPY ETF gained +14.3%. XXII has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -95.7% and -75.6%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
XXII support price is $.19 and resistance is $.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XXII shares will trade within this expected range on the day.
